Edoardo Marchesi - Concepedia

Author

Edoardo Marchesi

Fondazione IRCCS Istituto Nazionale dei Tumori

Also Known As

E Marchesi, E. Marchesi, Edoardo Marchesi

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Università degli Studi del Piemonte Orientale “Amedeo Avogadro”Mario Negri Institute for Pharmacological Research University of Milano-Bicocca

About

Edoardo Marchesi is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.6K
2	Cell Biology	11	11	1.6K
3	Immunology	6	6	518
4	Health Sciences	2	2	116
5	Medical Laboratory Science	1	1	13

Edoardo Marchesi

Publications

Citations

H-Index

Page 1

	Year	Citations
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells Valentina Zuco, Rosanna Supino, Sabina Carla Righetti, Cancer Letters Tumor BiologyOncogenic AgentMedicineSelective CytotoxicityBetulinic Acid	2002	521
Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification Philipp le Coutre, E. ̃Tassi, Marileila Varella‐Garcia, Blood	2000	487
In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor Philipp le Coutre, Luca Mologni, Loredana Cleris, JNCI Journal of the National Cancer Institute	1999	377
<i>In vitro</i> and <i>In vivo</i> Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells Miriam Puttini, Addolorata Maria Luce Coluccia, Frank Boschelli, Cancer Research Hematological MalignancyCell SignalingSki-606 ActivityMedicineImmunology	2006	368
Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis Carlo Gambacorti‐Passerini, Philipp le Coutre, Luca Mologni, Blood Cells Molecules and Diseases Hematological MalignancyCancer ResearchMixed-phenotype Acute LeukemiaInduces ApoptosisApoptosis	1997	317
Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein Said Dermime, F Grignani, M Clerici, Blood	1993	108
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab Paolo Bossi, Cristiana Bergamini, Marco Siano, Clinical Cancer Research PathologyCancer BiologyTumor BiologyRm-hnscc CancerTumor Heterogeneity	2016	94
In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acid Carlo Gambacorti‐Passerini, Luca Mologni, C Bertazzoli, Blood	1996	71
miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer Elisabetta Crippa, Lara Lusa, Loris De Cecco, PLoS ONE Tumor BiologyNon Brca1Breast OncologyEstrogen ReceptorCancer Cell Biology	2014	65
Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK-transformed cells Holger Ruchatz, Addolorata Maria Luce Coluccia, Paola Stano, Experimental Hematology Signal TransductionSignaling PathwayCell RegulationConstitutive ActivationJak-stat Signaling Pathway	2003	63

Page 1